Study of two multicenter, randomized branches with double masking, active control and parallel groups to investigate the effect of oral contraception with ethinylestradiol/drospirenone (0.02mg/0.15mg) in a 21/7 regimen on symptoms associated with hormonal deprivation in otherwise healthy women after 4 cycles of treatment.